Cecile Riviere-Cazaux is an MD PhD candidate with expertise in liquid biopsy development in neuro-oncology, including evaluation of cell-free DNA (cfDNA), proteomics, and metabolomics, as well as early phase clinical trial development. She is a lead author of several studies that evaluate the ability to utilize cerebrospinal fluid and plasma as liquid biopsy sources to improve response assessment for patients with gliomas. The team’s studies have also evaluated how a technique known as microdialysis can be used within and outside of the operating room to evaluate the glioma in its environment, in situ. Her work bridges neurosurgery, clinical oncology, and multiomics approaches to develop a “toolkit” for disease monitoring and pharmacodynamic assessment in brain cancer.